Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Influenza Diagnostic Market Expected To Grow In Terms Of Size?

There has been consistent growth in the influenza diagnostic market size over the past few years. The market is projected to expand from $2.73 billion in 2024 to $2.87 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the growth witnessed in the previous years include developments in e-commerce, labor scarcities, enhanced automation and productivity, improvements in supply chain management, increased labor costs, and governmental backing for automation and robotics.

Expectations are high for considerable expansion in the influenza diagnostic market in the coming years. Projections see the market swelling to $3.9 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. The predicted growth within the forecast period can be credited to factors like customization, scalability, environmental and sustainability objectives, a desire to enhance operational performance, and the necessity to align with modern supply chain dynamics. The projected period is also likely to witness major trends including the incorporation of advanced technology, robotic selection and packaging, autonomous mobile robotics, real-time data processing and analytics, AI-powered decision making, collaborative robotics, and breakthroughs in robotic technology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Market Forces Are Contributing To The Growth Of The Influenza Diagnostic Market?

The expansion of the influenza diagnostic market is anticipated to be fueled by the growing prevalence of rapid diagnostic tests. These tests, vital for confirming or denying the existence of a disease or condition, are seeing an increase due to their ability to yield swift, accurate results in the healthcare sector. Rapid influenza diagnostic tests (RIDTs), in particular, can identify influenza viral antigens within 10-15 minutes, boasting a moderate sensitivity of 50-70%. For instance, the Australian Institute of Health and Welfare confirmed that from 2021-22 to 2022-23, the quantity of diagnostic imaging services surged from 28.4 million to 29.7 million. Therefore, the use of rapid diagnostic tests plays a significant role in promoting the influenza diagnostic market’s growth.

How Is The Influenza Diagnostic Market Segmented Across Key Categories?

The influenza diagnosticmarket covered in this report is segmented –

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Subsegments:

1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)

2) By Viral Culture: Cell Culture; Egg-based Culture

3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay

5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

What Future-Focused Trends Are Anticipated In The Influenza Diagnostic Market?

Leading firms in the influenza diagnostic market have initiated the production of ground-breaking items like Lucira COVID-19 & Flu Home Test that delivers speedy qualitative detection collectively. The Lucira COVID-19 and Flu Home Test, a single-use test kit for domestic use, generates outcomes from nasal swabs collected by individuals in about 30 minutes. For example, in February 2023, Pfizer Inc., a pharmaceutical company based in the US, gained official approval for the Lucira COVID-19 & Flu Home Test. This test is capable of identifying both Influenza A and B, also referred to as the flu, and SARS-CoV-2, the originating virus of COVID-19.

Who Are The Major Stakeholders Operating In The Influenza Diagnostic Market?

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

How Do Regional Dynamics Influence The Influenza Diagnostic Market Performance?

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2025, By The Business Research Company

Immunofluorescence Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model